In a patient receiving systemic glucocorticoids who develops acute muscle weakness with hypokalemia, is the cause steroid‑induced hypokalemia rather than a primary hypokalemic periodic paralysis?

Steroid-Induced Hypokalemia vs. Primary Hypokalemic Periodic Paralysis

In a patient receiving systemic glucocorticoids who develops acute muscle weakness with hypokalemia, the cause is almost certainly steroid-induced hypokalemic paralysis rather than primary hypokalemic periodic paralysis, and this distinction is critical because treatment differs—steroid-induced cases require potassium replacement with caution to avoid rebound hyperkalemia, while primary periodic paralysis may require chronic management and genetic counseling.

Mechanism of Steroid-Induced Hypokalemia

Glucocorticoids trigger hypokalemia through transcellular potassium shift rather than total body potassium depletion. The mechanism involves:

• Stimulation of Na⁺-K⁺ ATPase activity, driving potassium into cells 1
• Insulin and amylin-mediated enhancement of this pump activity 1
• Insulin resistance causing hyperglycemia, which further promotes intracellular potassium shift 1
• This represents sequestration rather than true potassium wasting 2

Clinical Presentation and Timing

The temporal relationship between steroid administration and symptom onset is the most important diagnostic clue:

• Symptoms typically develop within 24 hours of glucocorticoid administration 3, 4
• Acute onset of flaccid paralysis, most commonly affecting lower extremities initially 5
• Profound hypokalemia (often <2.0 mmol/L) with U-waves on ECG 2
• Complete resolution within 24 hours after potassium repletion 2, 5

Recent case reports document this phenomenon across multiple glucocorticoid preparations:

• Dexamethasone injection 3, 5
• Betamethasone injection 2
• Intravenous methylprednisolone 4

Critical Distinguishing Features

Steroid-Induced Hypokalemic Paralysis:

• Temporal relationship: Symptoms within hours to 24 hours of steroid exposure 3, 4, 5
• No prior episodes without steroid exposure 3, 2, 5
• Complete recovery after single episode with potassium replacement 2, 5
• Risk of rebound hyperkalemia during treatment due to potassium redistribution 2

Primary Hypokalemic Periodic Paralysis:

• Recurrent episodes triggered by multiple factors (carbohydrates, exercise, rest, stress, cold) 5, 1
• Family history often present (inherited channelopathy) 2, 1
• Episodes occur independent of medication exposure 1
• Genetic mutations in calcium or sodium ion channels 2, 1

Treatment Approach and Critical Pitfalls

The key management principle is recognizing that steroid-induced hypokalemia represents intracellular sequestration, not total body depletion:

• Administer potassium replacement cautiously with both oral and intravenous routes 2
• Monitor closely for rebound hyperkalemia as potassium shifts back extracellularly 2
• Expect rapid resolution within 24 hours if steroid-induced 2, 5
• Avoid excessive potassium repletion to prevent iatrogenic hyperkalemia 2

Common pitfall: Aggressive potassium replacement assuming total body depletion can lead to dangerous hyperkalemia once the transcellular shift reverses 2.

Special Populations at Higher Risk

Thyrotoxic patients are at particularly high risk for steroid-induced hypokalemic paralysis:

• Poorly controlled hyperthyroidism amplifies the risk 4
• Monitor potassium levels at regular intervals for at least 24 hours after steroid administration 4
• Consider ECG monitoring in at-risk individuals 4

Patients with undiagnosed familial periodic paralysis may experience their first attack after steroid exposure:

• Glucocorticoids can unmask underlying channelopathies 1
• Even patients with normokalemic periodic paralysis can develop hypokalemic episodes with steroids 1
• Steroids should be administered with caution in patients with any history of unexplained weakness 1

Clinical Decision Algorithm

When evaluating acute weakness with hypokalemia in a patient on steroids:

1. Establish temporal relationship: Did symptoms begin within 24 hours of steroid administration? 3, 4, 5
2. Review medication history: Recent glucocorticoid exposure (any route, any preparation)? 3, 2, 4, 5
3. Assess prior episodes: Any history of similar weakness without steroid exposure? 2, 1
4. Check family history: Any relatives with periodic paralysis? 2, 1
5. Monitor ECG: Look for U-waves, QRS widening indicating severe hypokalemia 2

If steroid exposure within 24 hours + no prior episodes without steroids = steroid-induced hypokalemic paralysis is the diagnosis.

Prevention Strategies

For patients requiring glucocorticoid therapy who may be at risk:

• Ensure steroids are clinically indicated before administration 3
• Monitor vital signs and serum potassium in at-risk patients 3
• Consider alternatives when appropriate 3
• In thyrotoxic patients, optimize thyroid control before initiating high-dose steroids 4
• Educate patients about early warning signs 3

Glucocorticoids are a well-established but under-recognized trigger for hypokalemic paralysis 1, and clinicians should maintain high suspicion when this temporal relationship exists, particularly given the increasing reports of both iatrogenic and illicit steroid-induced cases 2.